Vitamin E intake and risk of amyotrophic lateral sclerosis.
about
Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron diseaseIntake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosisRisk factors for amyotrophic lateral sclerosisClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisPotential Environmental Factors in Amyotrophic Lateral SclerosisPhase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALSAtherosclerosis: A Link Between Lipid Intake and Protein Tyrosine NitrationCurrent pathways for epidemiological research in amyotrophic lateral sclerosis.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies.Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.Progress in therapy development for amyotrophic lateral sclerosisS[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosisNutritional status and risk of amyotrophic lateral sclerosis in Japan.Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1.Rosmarinic Acid Alleviates Neurological Symptoms in the G93A-SOD1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies.Physiotherapeutic conduct in amyotrophic lateral sclerosis.The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier.Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis.The role of mitochondrial DNA mutations and free radicals in disease and ageingNutrition and dietary supplements in motor neuron disease.Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress.Mitochondrial medicine for neurodegenerative diseases.Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials.The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.Motoneuron Disease: Basic Science.Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2.Rice Bran Dietary Supplementation Improves Neurological Symptoms and Loss of Purkinje Cells in Vitamin E-Deficient Mice.Dietary intake of fruits and beta-carotene is negatively associated with amyotrophic lateral sclerosis risk in Koreans: a case-control study.Amyotrophic lateral sclerosis and food intake.Differential expression of TAR DNA-binding protein (TDP-43) in the central nervous system of horses afflicted with equine motor neuron disease (EMND): a preliminary study of a potential pathologic marker.Current Approaches Including Novel Nano/Microtechniques to Reduce Silicone Implant-Induced Contracture with Adverse Immune Responses.GEMALS: A promising therapy for amyotrophic lateral sclerosis.Vitamin E
P2860
Q24243199-B4738395-6DDC-4757-8A08-56C8144EFCCCQ24678388-0CC9D504-98A9-4088-BC51-FC5ECE02903BQ26827642-0EE4D3F0-EA84-4E24-AA69-33E01E73D309Q28392768-E1CFF166-8E79-457E-B5AA-97F8F67D7285Q28393938-D9B26618-600A-498C-8D71-B554897A654FQ30494108-21E9CFF6-1B22-4A17-98CB-EDB4C4AC2BBAQ30619235-72136251-F5C0-45C9-8510-3EAABBB418FCQ33358054-1020A447-F832-4B6D-A2C6-E3372DE86789Q33649712-D245EDF8-FDAC-4717-9DA6-778F39C1C295Q33697436-0852FF27-3444-4792-BCA3-75B3093485CBQ33783000-F2810E17-A627-40E8-B89F-283CB98BA46AQ33824784-B70A1DB5-7A7F-48C3-8E32-C0CDA86A6AE2Q34160767-67902D92-5EC1-4C59-BAC7-A68A20E2BA03Q34571459-06A8CEB9-CC9A-47BF-99F1-4CAD047FFF19Q34593882-4F29DDCE-C615-4968-BF4F-01114705F7AEQ34640800-C656FD7F-A093-44D7-B862-9CFD9BAE8FD5Q34680962-D4039EAB-8E5B-4F8A-A8E0-8AA7ED3890D2Q34686665-9E9EF786-6EF0-4ED3-B2FC-A17F2FA92C10Q36114113-3656FDF5-A551-4086-88AA-2987A64D6669Q36396423-D016F3FC-1A5E-45D9-B611-1444FEC6C84AQ36717816-DEEB2283-D5C1-4144-BF96-03AE69FFBA9EQ36745426-644A2694-82CE-41C3-BF37-85D26E2BB245Q36898119-A116D5D6-6189-4C6F-8465-4A9B8B167AF6Q36904550-A37B61C7-2653-4424-AB7D-FA638DD4B992Q36910241-22C9A5F4-72B8-4EE4-B31B-9DFB8923D4A0Q37073851-9E3C85F2-27E1-486F-AC5D-E011AFE1A65CQ37564322-6FAD63B8-1D99-41B0-B20B-60779AB09FF8Q37672741-40F83B28-194A-420E-A233-197A863C4EA3Q37823334-59925A77-08C2-4CFC-B1BC-F7BA32BF7AFBQ38577066-72D7EE75-8FF7-416C-881D-E0B9100A8E3EQ39254848-589C5597-147E-4AE6-8C4E-11B558DD17E3Q39413091-0E38ADB2-085F-422B-81C5-00EC18BC93A8Q39904004-D1B479E6-9BC7-467E-B740-C2EBDB4A1BF1Q41319995-94458807-DB29-4183-8E1B-EFBC84B38CCAQ44754341-0781F216-DC78-4754-9026-0F297A98CE12Q47264044-3ED595D1-CD2F-4743-B09F-BF06670B60A4Q48400372-10667269-3A82-4C05-A8E8-A223D9BAD4D2Q52591902-17B54353-5CF1-49BC-AA68-ECF0D9D6D884Q52653087-4AD4C958-4D6E-42E7-B6BE-E5CF5EE465F6Q58320258-DC91BC23-318C-4E63-8924-265236ED57F2
P2860
Vitamin E intake and risk of amyotrophic lateral sclerosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@ast
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@en
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@nl
type
label
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@ast
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@en
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@nl
prefLabel
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@ast
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@en
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@nl
P2093
P356
P1433
P1476
Vitamin E intake and risk of amyotrophic lateral sclerosis.
@en
P2093
Eilis J O'reilly
Eric J Jacobs
Eugenia E Calle
Marc G Weisskopf
Marjorie L McCullough
Michael J Thun
P304
P356
10.1002/ANA.20316
P577
2005-01-01T00:00:00Z